IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

FDA accepts Sanofi's new diabetes drug application

11:41 PM MDT | July 7, 2014 | Natasha Alperowicz

Sanofi (Paris) said today that the US FDA has accepted for review the company’s new drug application for Toujeo, an investigational basal insulin. This follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicine Agency for EU countries on 27 May 2014. “By reaching this key milestone in the approval process, we are pleased to take another step forward with Toujeo, an investigational new based insulin that has been evaluated in a broad range of people living with diabetes,” said Pierre Chancel, senior...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa